SUSAN COATS: Open Payments
NPI 1316437825 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 84 payments from 21 companies in 2025. Trend: 2023 $1,778 · 2024 $1,660 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $377 |
| UCB, Inc. | 10 | $204 |
| PFIZER INC. | 12 | $160 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| Neurocrine BioSciences, Inc. | 7 | $137 |
| Genentech USA, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Eisai Inc. | 3 | $73 |
| SK Life Science, Inc. | 3 | $69 |
| JAZZ PHARMACEUTICALS INC. | 2 | $65 |
Products named: QULIPTA, Symbravo, INGREZZA, Nayzilam, NURTEC ODT, BOTOX, Ocrevus Zunovo, AJOVY.
Industry payments across OK — which companies pay providers there.
